ABSTRACT
PURPOSE: To draw attention to a novel treatment agent for vision loss associated with peripheral exudative hemorrhagic chorioretinopathy. METHODS: The case of an 83-year-old man suffering with loss of left visual acuity vision in the context of vitreous hemorrhage secondary to peripheral exudative hemorrhagic chorioretinopathy is described. RESULTS: Resolution of vitreous hemorrhage and subretinal hemorrhage was demonstrated after treatment with aflibercept. CONCLUSION: Peripheral exudative hemorrhagic chorioretinopathy is discussed in terms of its presentation, pathophysiology, and existing treatment methodologies.
Subject(s)
Angiogenesis Inhibitors/therapeutic use , Central Serous Chorioretinopathy/drug therapy , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Retinal Hemorrhage/drug therapy , Vitreous Hemorrhage/drug therapy , Aged, 80 and over , Central Serous Chorioretinopathy/diagnosis , Central Serous Chorioretinopathy/physiopathology , Exudates and Transudates , Humans , Intravitreal Injections , Male , Retinal Hemorrhage/diagnosis , Retinal Hemorrhage/physiopathology , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Visual Acuity/physiology , Vitreous Hemorrhage/diagnosis , Vitreous Hemorrhage/physiopathologyABSTRACT
PURPOSE: This study explores autologous neurosensory autograph for a patient with a chronic full-thickness macular hole (FTMH) and idiopathic macular telangiectasia type 2 (IMT2). OBSERVATIONS: The patient had a chronic 1355 µm FTMH and best corrected visual acuity (BCVA) of 2 logMAR units after two unsuccessful attempts to close the macular hole. Following a 25-gauge vitrectomy, a 2-disc diameter neurosensory autograft from the supertemporal retina was mobilized and secured with perfluoro-N-octane (PFO) tamponade. After being postured supine for one week, the PFO was exchanged for silicone oil. Two months later, silicone oil was exchanged for 20% sulphur hexafluoride (SF6). CONCLUSIONS AND IMPORTANCE: The graft achieved anatomical and functional success with BCVA of 0.6 logMAR units. This case supports autologous neurosensory autograph as a technique for achieving closure of chronic macular holes refractory to conventional treatment.
